Matches in Wikidata for { <http://www.wikidata.org/entity/Q59384061> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q59384061 description "im Juni 2012 veröffentlichter wissenschaftlicher Artikel" @default.
- Q59384061 description "scholarly article by Jana Skřičková et al published June 2012 in Lung Cancer" @default.
- Q59384061 description "wetenschappelijk artikel" @default.
- Q59384061 description "наукова стаття, опублікована в червні 2012" @default.
- Q59384061 name "The Czech Republic experience with erlotinib in the treatment of a non-selected non-small cell lung cancer (NSCLC) population of 2365 patients (pts)" @default.
- Q59384061 name "The Czech Republic experience with erlotinib in the treatment of a non-selected non-small cell lung cancer" @default.
- Q59384061 type Item @default.
- Q59384061 label "The Czech Republic experience with erlotinib in the treatment of a non-selected non-small cell lung cancer (NSCLC) population of 2365 patients (pts)" @default.
- Q59384061 label "The Czech Republic experience with erlotinib in the treatment of a non-selected non-small cell lung cancer" @default.
- Q59384061 prefLabel "The Czech Republic experience with erlotinib in the treatment of a non-selected non-small cell lung cancer (NSCLC) population of 2365 patients (pts)" @default.
- Q59384061 prefLabel "The Czech Republic experience with erlotinib in the treatment of a non-selected non-small cell lung cancer" @default.
- Q59384061 P1433 Q59384061-E29C2D71-B4AF-4C3D-AB6D-9062D70CB780 @default.
- Q59384061 P1476 Q59384061-D0E9AF2B-4713-4E68-BC02-70DD2738BBE6 @default.
- Q59384061 P2093 Q59384061-152BB337-1D6B-4C4D-BC66-4AC7F50553AC @default.
- Q59384061 P2093 Q59384061-2CCC5D65-E065-4AD5-9081-6B68AC5EAD0D @default.
- Q59384061 P2093 Q59384061-36314C95-7C8E-4931-A5F2-A17D4F3787CF @default.
- Q59384061 P2093 Q59384061-39B618F6-2643-4C52-A7C1-A21EE4368A02 @default.
- Q59384061 P2093 Q59384061-9DF3032C-14E2-4A44-A878-5E1909599F90 @default.
- Q59384061 P2093 Q59384061-E504391E-6E05-44C1-B869-D000ADABB400 @default.
- Q59384061 P2093 Q59384061-EF8DF6EA-E5FF-43C6-9F27-BA2F9F2229C1 @default.
- Q59384061 P2093 Q59384061-F3321772-F243-495F-8150-328320B83F82 @default.
- Q59384061 P304 Q59384061-09A1B953-462B-4B0A-8A88-3889C094C39C @default.
- Q59384061 P31 Q59384061-A6B54834-A065-482A-8BD3-2C630115F2AF @default.
- Q59384061 P356 Q59384061-62F4AE49-794F-4EA3-8CB3-731B5151F6A9 @default.
- Q59384061 P478 Q59384061-DC5BCE70-5AB9-4C09-87FA-C2C53DD2BFE8 @default.
- Q59384061 P50 Q59384061-2337555B-455C-45E9-9AE8-19775FF2555B @default.
- Q59384061 P50 Q59384061-89912F78-592E-4656-B204-CB85009BAC6B @default.
- Q59384061 P577 Q59384061-733F2A1B-6245-4047-9D80-84A77FA4E3DF @default.
- Q59384061 P921 Q59384061-8577A7BB-CCFE-41E3-BC5F-08254AFA11CD @default.
- Q59384061 P921 Q59384061-E3555FFD-B636-4749-BA73-97B6F65AF628 @default.
- Q59384061 P356 J.LUNGCAN.2012.05.075 @default.
- Q59384061 P1433 Q641464 @default.
- Q59384061 P1476 "The Czech Republic experience with erlotinib in the treatment of a non-selected non-small cell lung cancer (NSCLC) population of 2365 patients (pts)" @default.
- Q59384061 P2093 "František Salajka" @default.
- Q59384061 P2093 "Helena Čoupková" @default.
- Q59384061 P2093 "Jana Skřičková" @default.
- Q59384061 P2093 "Karel Hejduk" @default.
- Q59384061 P2093 "Leona Koubková" @default.
- Q59384061 P2093 "Petr Zatloukal" @default.
- Q59384061 P2093 "Vítězslav Kolek" @default.
- Q59384061 P2093 "Zdeněk Bortlíček" @default.
- Q59384061 P304 "S38" @default.
- Q59384061 P31 Q13442814 @default.
- Q59384061 P356 "10.1016/J.LUNGCAN.2012.05.075" @default.
- Q59384061 P478 "77" @default.
- Q59384061 P50 Q40128138 @default.
- Q59384061 P50 Q42632027 @default.
- Q59384061 P577 "2012-06-01T00:00:00Z" @default.
- Q59384061 P921 Q213 @default.
- Q59384061 P921 Q3658562 @default.